Status:
UNKNOWN
Study to Develop a Breath Analyser to Detect Chronic Kidney Disease
Lead Sponsor:
University College, London
Conditions:
Kidney Diseases
Eligibility:
All Genders
18-90 years
Brief Summary
Measure trimethylamine oxide in the breath.
Detailed Description
Organic compounds such as trimethylamine oxide (TMAO) accumulate in the blood of patients with kidney disease, and volatile compounds such as TMAO can be detected in the breath. The investigators wis...
Eligibility Criteria
Inclusion
- patients with kidney disease under the care of Royal Free Hospital
Exclusion
- patients unable to provide informed consent
- patients unable to exhale into breath analyser
Key Trial Info
Start Date :
February 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03303222
Start Date
February 10 2021
End Date
November 30 2023
Last Update
November 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.